While it shares some similarities in promoting muscle growth and recovery, it works through a different biological mechanism and is classified as a peptide hormone, not a steroid
University of Oklahoma researcher Elizabeth Wellberg, Ph.D., is the senior author of a review article in The Journal of Clinical Investigation that gathers current research evidence about the effects of GLP-1 drugs on cancer risk
Here's a clear breakdown of what each is: L-Carnosine: Dipeptide (made up of two amino acids: beta-alanine and histidine)
Experts in obesity medicine emphasize that GLP-1 receptor agonists like Wegovy are designed to be taken continuously to manage the underlying biological mechanisms that contribute to weight gain and difficulty losing weight
Looking for the next step in obesity pharmacotherapies, the concept of combining entero-pancreatic hormones for obesity treatment was supported by the marked WL, sustained weight maintenance, and metabolic benefits observed with BS, which increase multiple gut hormone levels [9,10,11,12,13,14]
Takeo YH, Shuster SA, Jiang L, Hu MC, Luginbuhl DJ, Rulicke T et al
